Ronald T. Brown

The Journal of Clinical Oncology recently published findings from a report that shows methylphenidate, a medicine widely used to treat attention deficit hyperactivity disorder (ADHD), also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors.

Wayne State University Provost and pediatric psychologist Ronald T. Brown is available to discuss the impact and significance of the study's findings and the potential benefits of the medication for children at risk of cognitive impairment.

Brown, who specializes in children and adolescents with chronic illnesses, attention deficit disorders and learning disabilities, served as dean of the College of Health Professions at Temple University for six years before joining Wayne State. He holds a Ph.D. from Georgia State University and a B.A. from Emory University. Brown is a fellow of the American Psychological Society, the American Psychological Association and the Society of Pediatric Psychology and is a Diplomate in clinical health psychology of the American Board of Professional Psychology.

To set up an interview with Brown, call Francine Wunder at (313) 577-8155.

MORE INFO: Brown can also comment on childhood medications, pediatric psychopharmacology and neurological diseases, learning disabilities, and emotional problems in children.
 

Wayne State University is a premier urban research university offering more than 400 academic programs through 13 schools and colleges to nearly 32,000 students.